Articles by: Michael Fisher

Shinsei stock jumps amid news on massive acquisition deal

Shinsei shares increased 2.04% in Tuesday trading, following the banking company’s statement for a major acquisition. The Japanese financial institution announced that it will acquire one of the biggest non-bank finance providers in New Zealand, UDC Finance Ltd. To this day, this will be the biggest overseas acquisition deal for Shinsei. The Japanese company is […] Read more

Target shares drop after temporarily closing stores amid violent protests

Amid the protests that spread across the US and the simmering Sino-US tensions, Wall Street futures remained steady in Monday trading. This being said, the protests against police brutality and racism caused a drop in the shares of some companies that were forced to close stores or adjust their working hours. Target’s shares declined 2% […] Read more

Mediobanca shares rise after billionaire Leonardo Del Vecchio requests stake increase

European shares increased on Monday as hopes for economic recovery were restored. Investors were relieved after President Trump’s warnings towards China were not as harsh as everyone expected. This led to a 1% jump of the STOXX 600 Index in early Monday trading, with a potential for a three-month high for European shares. The Italian […] Read more

Sonoma Pharmaceuticals shares jump, company disinfectant to be used against COVID-19

Sonoma Pharmaceuticals’ shares almost tripled in premarket trading Friday. The huge jump is due to the latest news surrounding one of the company’s products. Sonoma Pharmaceuticals, along with MicroSafe Group, developed the Nanocyn disinfectant and sanitizer, which was added to the Australian Register of Therapeutic Goods (ARTG) and can be used against COVID-19. In premarket […] Read more

JDE Peet’s shares surge after huge IPO launch

Friday was JDE Peet’s stock market debut and the company’s shares surged 13%. Investors were impressed by the coffee retailer’s IPO, which was one of the few high debuts on the stock market during the coronavirus pandemic. JDE Peet’s is the owner of brands like Douwe Egberts, Peet’s Coffee and Jacobs and its shares were […] Read more

General Electric shares close lower after disappointing cash flow predictions

On Thursday, General Electric’s shares dropped 3.2%, following the warnings of bigger cash burn for the second quarter of 2020. The CEO of the company, Larry Culp, stated at an investors conference that the aviation division of General Electric was severely damaged due to the pandemic crisis. This is why it came as no surprise […] Read more

Twitter stock drops in premarket, Trump to announce order targeting social media companies

The social media stocks will be one of the investors’ main focuses in Thursday trading. Following President Trump’s statement for signing an executive order against social media companies, Twitter’s stock declined 2.7% in premarket trading. The executive order is due to be signed on Thursday and it targets social media companies like Twitter and Facebook. […] Read more

JPMorgan Chase & Co. shares surge, second quarter revenue to surpass 2019 results

Wall Street stocks rose in Wednesday trading, with the financial and industrial sectors leading the jump in shares. JPMorgan Chase & Co. was among the top performers on Wednesday, with shares going up 4%. Bank stocks surged significantly as investors were motivated by the hope for recovery that sprung up after businesses started reopening. In […] Read more

International Airlines Group shares surge, European stocks rise amid EU recovery fund proposal

On Wednesday, the European stocks rose as investors hoped that the European Union would soon introduce a massive stimulus recovery plan. Airlines ranked as the top performers in Wednesday trading and the Stoxx Europe 600 Index rose 0.3% to 350.21. The shares of the Anglo-Spanish airline company, International Airlines Group (IAG), jumped 5%. Meanwhile, TUI […] Read more

Sanofi stock closes low despite $13 billion deal on Regeneron shares

Sanofi’s shares closed lower in Tuesday trading despite the recent deal for selling its shares in the U.S. biotechnology company Regeneron. Sanofi will earn about $13 billion after selling a huge part of its 20.6% stake in Regeneron. Despite that, the company’s shares dropped 1% on Tuesday, along with other healthcare companies’ stocks. On Monday, […] Read more